The aim of this article is to provide nurse practitioners with a better understanding of the transition from chlorofluorocarbon (CFC) to hydrofluoralkane (HFA) metered-dose inhalers (MDIs). The authors discuss the differences in these products' propellants; the proper use, cost, and efficacy of the HFA inhalers; and the implications of the switch for NPs and for their patients with asthma.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675349 | PMC |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!